European Medical Writers Association and Institute of Clinical Research are delighted to invite you to their first joint symposium. The theme is the “hot topic” of the ethical minefield of publishing clinical trial results.
Patients nowadays wish to have more and more information about their medicines, and the pharmaceutical industry is obliged to improve transparency regarding clinical research programmes. It is more important than ever for pharmaceutical companies to understand their ethical imperatives.
Journal editors are faced with the constant challenge of ensuring that high standards of ethicsand transparency are met. Recent guidelines have helped to define the role of medical writers, but their involvement remains controversial. These are just some of the topics that will be presented and discussed during this exciting one-day event.
The Programme
9.15 Registration
9.45-10.10 Publications: Purpose and Process
Dr Julia Donnelly, Julia Donnelly Solutions Ltd
10.10-10.40 Fraud in Publications
Dr Harvey Marcovitch,
Chairman, Committee on Publication Ethics
10.40-11.10 Authorship, Guests and Ghosts
Elise Langdon-Neuner, Director of Preclinical
Documents & Scientific Communications,
Baxter BioScience, Austria
11.10-11.30 Break
11.30-12:00 Ghostwriting: What’s the Problem?
Professor David Healey, Professor of Psychiatry,
Cardiff University
12.00-12.30 Panel discussion with Q&A
12.30-14.00 Lunch
14.00-14.30 A Journal Editor’s Perspective of Industry
Practices
Dr Trish Groves, Deputy Editor, British Medical
Journal
14.30-15.00 Publication Policies: Why Every Company
Needs One
Liz Wager, Publications Consultant, Sideview
15.00-15.20 Break
15.20-15.50 The View from ‘Big Pharma’
Dr Valerie Siddall, Global Director of Publications,
AstraZeneca
15.50-16.20 Panel discussion with Q&A
16.20-16.30 Conference wrap up
Adam Jacobs, Director, Dianthus Medical Ltd
Bring your own Ouija Board.
No comments:
Post a Comment